TLSI Relative Valuation
TLSI's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, TLSI is overvalued; if below, it's undervalued.
Historical Valuation
TriSalus Life Sciences Inc (TLSI) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -4.08. The fair price of TriSalus Life Sciences Inc (TLSI) is between NaN to NaN according to relative valuation methord.
Relative Value
Fair Zone
NaN-NaN
Current Price：6.69
Fair
-25.82
PE
1Y
3Y
5Y
Trailing
Forward
-107.33
EV/EBITDA
TriSalus Life Sciences Inc. (TLSI) has a current EV/EBITDA of -107.33. The 5-year average EV/EBITDA is -8.65. The thresholds are as follows: Strongly Undervalued below -44.31, Undervalued between -44.31 and -26.48, Fairly Valued between 9.18 and -26.48, Overvalued between 9.18 and 27.01, and Strongly Overvalued above 27.01. The current Forward EV/EBITDA of -107.33 falls within the Strongly Undervalued range.
-44.07
EV/EBIT
TriSalus Life Sciences Inc. (TLSI) has a current EV/EBIT of -44.07. The 5-year average EV/EBIT is -5.98. The thresholds are as follows: Strongly Undervalued below -21.90, Undervalued between -21.90 and -13.94, Fairly Valued between 1.97 and -13.94, Overvalued between 1.97 and 9.93, and Strongly Overvalued above 9.93. The current Forward EV/EBIT of -44.07 falls within the Strongly Undervalued range.
5.35
PS
TriSalus Life Sciences Inc. (TLSI) has a current PS of 5.35. The 5-year average PS is 3.15. The thresholds are as follows: Strongly Undervalued below -3.49, Undervalued between -3.49 and -0.17, Fairly Valued between 6.48 and -0.17, Overvalued between 6.48 and 9.80, and Strongly Overvalued above 9.80. The current Forward PS of 5.35 falls within the Historic Trend Line -Fairly Valued range.
61.61
P/OCF
TriSalus Life Sciences Inc. (TLSI) has a current P/OCF of 61.61. The 5-year average P/OCF is -3.04. The thresholds are as follows: Strongly Undervalued below -33.64, Undervalued between -33.64 and -18.34, Fairly Valued between 12.26 and -18.34, Overvalued between 12.26 and 27.56, and Strongly Overvalued above 27.56. The current Forward P/OCF of 61.61 falls within the Strongly Overvalued range.
267.84
P/FCF
TriSalus Life Sciences Inc. (TLSI) has a current P/FCF of 267.84. The 5-year average P/FCF is 12.98. The thresholds are as follows: Strongly Undervalued below -81.93, Undervalued between -81.93 and -34.47, Fairly Valued between 60.43 and -34.47, Overvalued between 60.43 and 107.89, and Strongly Overvalued above 107.89. The current Forward P/FCF of 267.84 falls within the Strongly Overvalued range.
TriSalus Life Sciences Inc (TLSI) has a current Price-to-Book (P/B) ratio of -12.00. Compared to its 3-year average P/B ratio of -3.79 , the current P/B ratio is approximately 216.99% higher. Relative to its 5-year average P/B ratio of -2.61, the current P/B ratio is about 360.58% higher. TriSalus Life Sciences Inc (TLSI) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of -25.47%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of -18.07% , the current FCF yield is about -100.00% lower.
-12.51
P/B
Median3y
-3.79
Median5y
-2.61
-6.90
FCF Yield
Median3y
-25.47
Median5y
-18.07
Competitors Valuation Multiple
The average P/S ratio for TLSI's competitors is , providing a benchmark for relative valuation. TriSalus Life Sciences Inc Corp (TLSI) exhibits a P/S ratio of , which is NaN% above the industry average. Given its robust revenue growth of 57.38%, this premium appears sustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
Performance Decomposition
1Y
3Y
5Y
Market capitalization of TLSI increased by 33.73% over the past 1 year. The primary factor behind the change was an decrease in Margin Expansion from -32.64 to -93.47.
The secondary factor is the Revenue Growth, contributed 57.38%to the performance.
Overall, the performance of TLSI in the past 1 year is driven by Margin Expansion. Which is more sustainable.
People Also Watch
FAQ
Is TriSalus Life Sciences Inc (TLSI) currently overvalued or undervalued?
What is TriSalus Life Sciences Inc (TLSI) fair value?
How does TLSI's valuation metrics compare to the industry average?
What is the current P/B ratio for TriSalus Life Sciences Inc (TLSI) as of Dec 05 2025?
What is the current FCF Yield for TriSalus Life Sciences Inc (TLSI) as of Dec 05 2025?
What is the current Forward P/E ratio for TriSalus Life Sciences Inc (TLSI) as of Dec 05 2025?